GENEXINE

Genexine is a leading biopharmaceutical company focused on discovering, developing and commercializing first and best-in-class immunotherapies for cancer and antibody therapies for rare diseases. With its headquarters located in Seoul South Korea, Genexine is currently undergoing a transformation to be the first Korean biopharmaceutical company to expand onto the global stage... With 22 years of history, Genexine is now focusing its efforts on becoming a leading, global biopharmaceutical company by 2030. The company has built a solid scientific foundation for growth through strong R&D, CMC and development capabilities. It is now poised to expand beyond the Korean borders to complement its drug development efforts on a global scale. Genexine's goal is to become the first Korean global biopharmaceutical company... Expanding beyond Korea will enable Genexine to broaden its access to technology, markets and expertise. Genexine is unique in that it has access to a strong talent base and..

Also known as: Genexine, Inc.

Primary location: Seoul South Korea